Ray Dalio's MDT Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 338,201 shares of Medtronic plc (MDT) worth $32.21 M, representing 0.13% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 43 quarters.
Based on 13F filings since 2013, Ray Dalio has maintained a long-term strategic position in MDT, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2022, adding 1.85 M shares. Largest reduction occurred in Q1 2024, reducing 1.83 M shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Medtronic plc (MDT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medtronic plc (MDT) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2015 | +172,832 | New Buy | 172,832 | $77.99 |
| Q2 2015 | -87,700 | Reduce 50.74% | 85,132 | $74.10 |
| Q3 2015 | -27,946 | Reduce 32.83% | 57,186 | $66.94 |
| Q4 2015 | -4,000 | Reduce 6.99% | 53,186 | $76.92 |
| Q1 2016 | -53,186 | Sold Out | 53,186 | $0.00 |
| Q3 2016 | +31,000 | New Buy | 31,000 | $86.39 |
| Q4 2016 | +31,300 | Add 100.97% | 62,300 | $71.24 |
| Q1 2017 | -62,300 | Sold Out | 62,300 | $0.00 |
| Q4 2017 | +25,152 | New Buy | 25,152 | $80.75 |
| Q1 2018 | -25,152 | Sold Out | 25,152 | $0.00 |
| Q1 2022 | +1.88 M | New Buy | 1.88 M | $110.95 |
| Q2 2022 | +625,168 | Add 33.25% | 2.51 M | $89.75 |
| Q3 2022 | -2.51 M | Sold Out | 2.51 M | $0.00 |
| Q1 2024 | +680,227 | New Buy | 680,227 | $87.15 |
| Q2 2024 | +698,741 | Add 102.72% | 1.38 M | $78.71 |
| Q3 2024 | -796,240 | Reduce 57.74% | 582,728 | $90.03 |
| Q4 2024 | -71,379 | Reduce 12.25% | 511,349 | $79.88 |
| Q1 2025 | -341,753 | Reduce 66.83% | 169,596 | $89.86 |
| Q2 2025 | +32,570 | Add 19.20% | 202,166 | $87.17 |
| Q3 2025 | +136,035 | Add 67.29% | 338,201 | $95.24 |
Ray Dalio's Medtronic plc Investment FAQs
Ray Dalio first purchased Medtronic plc (MDT) in Q1 2015, acquiring 172,832 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Medtronic plc (MDT) for 43 quarters since Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to Medtronic plc (MDT) was in Q1 2022, adding 1,880,088 shares worth $208.6 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 338,201 shares of Medtronic plc (MDT), valued at approximately $32.21 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Medtronic plc (MDT) represents approximately 0.13% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in Medtronic plc (MDT) was 2,505,256 shares, as reported at the end of Q2 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.